Among these, 1 in 4 will likely have a repeated infection
E.NoverrM
Despite the lack of rigorous clinical studies, case studies and independent experimental use have consistently yielded good results with few reports of adverse effects
The effectiveness data available to date together with the basic biology studies most certainly warrant further research into this compound in the conditions discussed here and in clinical scenarios reviewed elsewhere [6]
Traditional formulations often suffer from issues like: Poor encapsulation of sensitive or water-repelling (hydrophobic) actives Inconsistent particle size, leading to unpredictable bioavailability and targeting Rapid degradation or leakage, resulting in short shelf life Difficulties maintaining performance when scaling from lab to production Liposome encapsulation solves these problems by: Maximizes absorption, especially for oral and topical delivery Extends circulation time for longer therapeutic effect Minimizes toxicity through targeted or controlled release Shields fragile actives such as mRNA, enzymes, and probiotics from degradation At BOC Sciences, we address these obstacles head-on through advanced liposome encapsulation technology
For example, in the study by Novinscak et al